Subcutaneous rituximab versus intravenous rituximab – safety and efficacy results
The relationship between basic and clinical research in CML
Can the cytomegalovirus be predicted by ELISpot assays?
Prof. Mohty on COMy 2017 - opportunity to discuss multiple myeloma research & clinical practice
Why aren’t cytogenetic analyses being implemented into clinical studies of CLL?